Long-term results of sphenopalatine ganglioneurectomy for facial pain

Cepero, Ralph; Miller, Robert H.; Bressler, Kyle L.

doi:10.1016/s0196-0709(87)80041-8

Cited by 25 publications

(14 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As the SPG has an important role on different pain syndromes, SPG blockade has an important role on the management of TN type 2. Many attempts including the removal of SPG cells, known as sphenopalatine ganglioneurectomy or radiosurgical neuroablation techniques have been described in the literature with varying success rates (Cepero et al 1987 ; Karas et al 2008 ). Besides, minimal invasive techniques via transnasal or infrazygomatic approaches described for modulating the action of SPG with different success rates.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of sphenopalatine ganglion blockade via intra oral route for the management of atypical trigeminal neuralgia

Çöven

Dayisoylu

2016

SpringerPlus

View full text Add to dashboard Cite

BackgroundThe sphenopalatine ganglion (SPG) may be involved in persistent idiopathic facial pain and unilateral headaches. The role of SPG blockade via intra oral route in the management of trigeminal neuralgia (TN) is worthy of study.MethodsIn this retrospective study, patient records included patients with atypical TN (type 2) that persisted in spite of conservative treatment for at least 2 years, and an average pain intensity from the craniofacial region visual analogue scale (VAS) before examination. In group I the patients received carmapazepin 800 mg a day for at least 2 years. In group II 3 ml of local anesthetic agent consisting 2 ml bupivacaine and 1 ml prilocain in addition to 1 ml fentanyl, 0.5 ml betametasone disodium phosphate and 0.5 ml opaque was injected by the intraoral route. In this group, injection procedures were performed under local anesthesia with fluoroscopic guidance. The Kruskal–Wallis and Mann–Whitney U tests with Bonferroni correction were used for intergroup analysis. Age and sex differences were evaluated with one-way ANOVA and Fisher’s exact tests, respectively.ResultsSignificant differences were found between pre-op and 3rd day VAS values and also pre-op and 1st month VAS values. No significant differences were found between pre-op and 6th month VAS values.ConclusionThe SPG blockade improves the quality of life of patients and a minimally-invasive procedure to management of TN, when compared to other methods.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of sphenopalatine ganglion blockade via intra oral route for the management of atypical trigeminal neuralgia

Çöven

Dayisoylu

2016

SpringerPlus

View full text Add to dashboard Cite

show abstract

“…In addition, sphenopalatine ganglion block treatment is not highly specific; it seems not enough as a diagnostic criterion. 3,20,24 Therefore, we do not recommend sphenopalatine ganglion block treatment as a criterion supporting the diagnosis of clinically established SN (Table 3).…”

Section: Discussionmentioning

confidence: 99%

“…In those cases in which no etiology was reported, blockage by cocainization or infiltration anesthesia of the pterygopalatine ganglion (PPG, namely sphenopalatine ganglia) was effective. 8,10,20 Due to a lack of follow-up data, the recurrence rate among these patients could not be determined. There is no evidence-based literature on the recommended pharmacological treatment of sphenopalatine ganglion neuralgia.…”

Section: Case Reports-patientmentioning

confidence: 99%

Sphenopalatine Neuralgia: An Independent Neuralgia Entity. Pooled Analysis of a Case Series and Literature Review

Zhang

Long

et al. 2019

Headache

View full text Add to dashboard Cite

Background Structural damage or demyelization of the sphenopalatine ganglion may cause sphenopalatine neuralgia (SN). The current International Classification of Headache Disorders, third edition (ICHD‐3) regards SN as a phenotype of cluster headache. Whether SN is an independent neuralgia entity has been debated for years. Methods This article presents a case series of SN, a review of all published cases, and a pooled data analysis of the identified cases. Results Seven patients were identified, with a median age at symptom onset of 59 years. Six cases were secondary to structural lesions surrounding the ipsilateral sphenopalatine ganglion, and all of them experienced significant clinical improvements after removing the primary causes. In the seventh patient, no evidence of underlying disease was found. The literature review showed that SN affected patients spanning a wide range of ages and both sexes. The clinical characteristics of SN might mimic cluster headache with the exception of cluster pattern and treatment response to oxygen. The typical duration of pain episodes in SN was several hours to several days; and in some cases, pain was persistent. Sixty‐seven percent (59/88) of patients with SN had structural lesions around the sphenopalatine ganglion. Conclusion SN could possibly be regarded as a different clinical entity from cluster headache. Based on our patients and literature review, SN can be categorized as idiopathic SN and secondary SN. Craniofacial structural lesions should be highly rating and taken into account when SN is suspected.

show abstract

“…In our database search and secondary review of references we located 47 rhizotomy studies that generally concerned spinal or facet pain and facial pain syndromes (Table 1). In the majority of the studies (34 of 47) the data reported were relevant to either TN (Table 1, first section; 20 studies) 8,13,14,17,63,79,90,92,95,102,118,122,133,135,142,150,160,163,165,166 or LFS (Table 1, second section; 14 studies 6 ,28,30,43,70,74,88,91,112, 117,130,145,146,153 ), whereas in the remainder the effects of rhizotomy on a variety of truncal and extremity neuralgias ( Table 1, third section; 1 study 87 ), cervical pain (Table 1, fourth section; 9 studies 7 ,45,75,78,113,132,147,148,151 ) or cluster headaches (Table 1, fifth section; 3 studies 19,93,134 ) were evaluated.…”

Section: Rhizotomy Studiesmentioning

confidence: 99%

“…Pain. Two retrospective studies (19 patients) 19,134 and 1 prospective study (18 patients) were reviewed. In the prospective study, 93 83% of patients had immediate pain relief but also demonstrated a 39% recurrence rate at long-term follow-up (Table 1, fifth section; 3 studies).…”

Section: Rhizotomy and Neurectomy For Cluster Headache And Facialmentioning

confidence: 99%

Destructive procedures for the treatment of nonmalignant pain: a structured literature review

Cetas

Saedi

Burchiel

2008

JNS

View full text Add to dashboard Cite

show abstract

Long-term results of sphenopalatine ganglioneurectomy for facial pain

Cited by 25 publications

References 7 publications

Evaluation of sphenopalatine ganglion blockade via intra oral route for the management of atypical trigeminal neuralgia

Evaluation of sphenopalatine ganglion blockade via intra oral route for the management of atypical trigeminal neuralgia

Sphenopalatine Neuralgia: An Independent Neuralgia Entity. Pooled Analysis of a Case Series and Literature Review

Destructive procedures for the treatment of nonmalignant pain: a structured literature review

Contact Info

Product

Resources

About